This inventor holds 1 USPTO granted patent. Top assignee: Pls-Design Gmbh. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovations of Benjamin Bockisch
Introduction
Benjamin Bockisch is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of allergen research. His work focuses on the cloning of honey bee allergens, which has important implications for allergy diagnostics and treatments.
Latest Patents
Bockisch holds a patent for the cloning of honey bee allergen C. This invention relates to a nucleic acid encoding a polypeptide capable of binding to IgE from subjects allergic to the venom of an insect. The polypeptide has a homology of more than 70% to the amino acid sequence of SEQ ID NO: 2, which is identified as the honey bee allergen C (Api m 5). The patent also covers expression vectors, host cells, and polypeptides encoded by the nucleic acid, along with their diagnostic and pharmaceutical uses.
Career Highlights
Bockisch is currently employed at Pls-Design GmbH, where he continues to advance his research in allergen-related technologies. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the understanding and treatment of insect venom allergies.
Collaborations
He collaborates with notable colleagues such as Simon Blank and Thomas Grunwald, who share his passion for advancing scientific knowledge in the field of allergen research.
Conclusion
Benjamin Bockisch's contributions to the field of biotechnology, particularly through his patent on honey bee allergen C, highlight his role as an influential inventor. His work not only enhances our understanding of allergies but also paves the way for future advancements in allergy diagnostics and treatments.